Jones Financial Companies
EDIT icon

Jones Financial Companies’s Editas Medicine EDIT Stock Holding History

Jones Financial Companies’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24K Sell
1,839
-230
-11% -$672 ﹤0.01% 4069
2026
Q1 		$4.61K Buy
2,069
+128
+7% +$271 ﹤0.01% 3874
2025
Q4 		$3.98K Buy
1,941
+571
+42% +$1.65K ﹤0.01% 3588
2025
Q3 		$4.44K Buy
1,370
+125
+10% +$349 ﹤0.01% 3406
2025
Q2 		$2.84K Sell
1,245
-875
-41% -$1.43K ﹤0.01% 3349
2025
Q1 		$2.65K Buy
2,120
+617
+41% +$908 ﹤0.01% 3179
2024
Q4 		$1.91K Buy
1,503
+108
+8% +$275 ﹤0.01% 3009
2024
Q3 		$4.86K Buy
+1,395
New +$6.07K ﹤0.01% 2453

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jones Financial Companies's EDIT Position: Q2 2026 in Review

Jones Financial Companies reduced its Editas Medicine (EDIT) stake by 11% in Q2 2026, selling an estimated $672 and leaving 1,839 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #4069.

Jones Financial Companies first reported a position in EDIT in Q3 2024 and has held it in 8 quarters since. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Jones Financial Companies held 1,839 shares of Editas Medicine worth $5.24K as of Q2 2026.
  • Jones Financial Companies sold 230 Editas Medicine shares in Q2 2026, an estimated $672.
  • Editas Medicine made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4069 holding.
  • Jones Financial Companies first reported a position in Editas Medicine in Q3 2024 and has held it in 8 quarters since.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.